Auriga Starts Protalix BioTherapeutics (PLX) at Buy
Tweet
Share
E-mailGet Alerts PLX Hot Sheet
Price: $2.37 +2.16%
Rating Summary:
3 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 15 | Down: 20 | New: 23
Rating Summary:
3 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 15 | Down: 20 | New: 23
Join SI Premium – FREE
Auriga initiates coverage on Protalix BioTherapeutics (NYSE: PLX) with a Buy. PT $8.00.
For an analyst ratings summary and ratings history on Protalix BioTherapeutics click here. For more ratings news on Protalix BioTherapeutics click here.
Shares of Protalix BioTherapeutics closed at $5.85 yesterday.
For an analyst ratings summary and ratings history on Protalix BioTherapeutics click here. For more ratings news on Protalix BioTherapeutics click here.
Shares of Protalix BioTherapeutics closed at $5.85 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Raymond James Starts Civeo (CVEO) at Strong Buy
- Wolfe Research Starts SK Hynix (SKHY) at Outperform
- Bernstein SocGen Group Starts Minimax Group Inc (100:HK) at Market Perform
Create E-mail Alert Related Categories
New CoverageRelated Entities
AurigaSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
